Company / Return on Assets (ROA)
Aurinia Pharmaceuticals Inc. Return on Assets (ROA) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
38.2%
FY2025
5-year range
-21.8% / 38.2%
FY2021-FY2025
Trend
+3574.0%
vs FY2024
Sector context
#4 of 213
Health Care
What the data says
Return on Assets (ROA) changed +3574% YoY in FY2025, a notable deviation from the 6-year average annual change of +621%.
Based on SEC 10-K filings.
38.2% in FY2025 with a 5-year CAGR of +60.4%. Top quartile in the Health Care sector.
Improved from -14.2% to 38.2% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +60.0pp
- 5-Year Change
- +60.4pp
- 10-Year Change
- -
Sector benchmark
Top 2% in Health CareTop 2% of 213This company 38.2% Sector average -24.2%
▼
+258.1% above sector average
Key checks
Key Insights
- Aurinia Pharmaceuticals Inc.'s return on assets (roa) has grown for 3 consecutive years.
- In FY2025, return on assets (roa) increased 3574.0% year-over-year.
- Currently 62.4pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 38.2% | +3574.0% |
| FY2024 | 1.0% | +107.3% |
| FY2023 | -14.2% | +34.7% |
| FY2022 | -21.8% | -34.1% |
| FY2021 | -16.3% | +26.5% |
| FY2020 | -22.1% | +18.7% |
| FY2019 | -27.3% | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026